Prelude Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,988
| Closed | -$215K | – | 1963 |
|
|
2020
Q4 | $215K | Sell |
2,988
-33,269
| -92% | -$1.74M | 0.01% | 1086 |
|
|
2020
Q3 | $1.65M | Buy |
+36,257
| New | +$1.52M | 0.08% | 184 |
|
|
2020
Q1 | – | Sell |
-87
| Closed | -$4K | – | 2331 |
|
|
2019
Q4 | $4K | Buy |
+87
| New | +$3.77K | ﹤0.01% | 1799 |
|
|
2019
Q1 | – | Sell |
-106
| Closed | -$6K | – | 2425 |
|
|
2018
Q4 | $6K | Sell |
106
-94
| -47% | -$5.64K | ﹤0.01% | 1602 |
|
|
2018
Q3 | $13K | Sell |
200
-55,231
| -100% | -$3.08M | ﹤0.01% | 1416 |
|
|
2018
Q2 | $2.49M | Sell |
55,431
-10,513
| -16% | -$419K | 0.16% | 112 |
|
|
2018
Q1 | $2.05M | Buy |
65,944
+2,908
| +5% | +$95.6K | 0.15% | 116 |
|
|
2017
Q4 | $1.89M | Buy |
63,036
+32,562
| +107% | +$943K | 0.15% | 140 |
|
|
2017
Q3 | $1.01M | Buy |
+30,474
| New | +$1.06M | 0.09% | 242 |
|
|
2017
Q2 | – | Sell |
-38,162
| Closed | -$1.1M | – | 2073 |
|
|
2017
Q1 | $1.1M | Sell |
38,162
-16,904
| -31% | -$419K | 0.11% | 217 |
|
|
2016
Q4 | $1.23M | Sell |
55,066
-1,755
| -3% | -$34.3K | 0.15% | 174 |
|
|
2016
Q3 | $1.05M | Buy |
56,821
+9,789
| +21% | +$185K | 0.11% | 205 |
|
|
2016
Q2 | $767K | Buy |
47,032
+34,532
| +276% | +$508K | 0.11% | 213 |
|
|
2016
Q1 | $146K | Buy |
+12,500
| New | +$140K | 0.02% | 644 |
|
|
2015
Q2 | – | Sell |
-17,968
| Closed | -$159K | – | 2372 |
|
|
2015
Q1 | $159K | Buy |
+17,968
| New | +$182K | 0.02% | 753 |
|
|
2013
Q3 | – | Sell |
-2,124
| Closed | -$13K | – | 1943 |
|
|
2013
Q2 | $13K | Buy |
+2,124
| New | +$7.15K | ﹤0.01% | 893 |
|
Other funds holding BEAT
Prelude Capital Management's BEAT Position: Q1 2021 in Review
Prelude Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 2,988 shares — an estimated $215K sold.
Prelude Capital Management first reported a position in BEAT in Q2 2013 and held it in 16 quarters. The position peaked at $2.49M in Q2 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Prelude Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Prelude Capital Management sold 2,988 BioTelemetry, Inc. shares in Q1 2021, an estimated $215K.
- Prelude Capital Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 16 quarters.
- Prelude Capital Management's BioTelemetry, Inc. position peaked at $2.49M in Q2 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Prelude Capital Management's 13F filing for Q1 2021, filed 17 May 2021.